Why the study?
Does Coxsackievirus B4 persistently infect human thymic epithelial cells and alter their proliferation and cytokine production?
Does Coxsackievirus B4 persistently infect human thymic epithelial cells and alter their proliferation and cytokine production?
Coxsackievirus B4 can persistently infect human thymic epithelial cells, leading to increased cell proliferation and chronic cytokine production, which may have implications for viral-induced autoimmunity.
Answers are grounded in this paper and cite their sources.
Persistent CVB4 infection may alter TEC function via cytokines; hypothesis-generating for viral-triggered autoimmunity.
Persistent replication of coxsackievirus B4 (CVB4) E2 (diabetogenic) and CVB4 JBV (nondiabetogenic) strains in thymic epithelial cell (TEC)-enriched cultures (>or=95%) was proved by detection of positive- and negative-strand viral RNA by reverse transcription-PCR in extracted RNA from cell cultures, VP1 capsid protein detection by immunofluorescence (IF) staining, and release of infectious particles up to 30 days after infection without obvious cytolysis. By double-IF staining, cytokeratin-containing cells were shown to be susceptible to CVB4. The persistence of CVB4 was associated with a significantly increased rate of TEC proliferation (up to 70%) after 20 days of culture and a significantly increased chronic production of immunoreactive interleukin-6 (IL-6), leukemia inhibitory factor, and granulocyte-macrophage colony-stimulating factor in supernatant after 3 days of culture. The CVB4 replication and the release of cytokines were not restricted to the CVB4 E2 diabetogenic strain and did not depend on the genetic background of the host; however, TEC were more responsive to CVB4 E2 than CVB4 JBV as far as the production of cytokines.
No takes yet. Share an insight, caveat, or question.
Brilot et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: